Medicine and Dentistry
Glucagon Like Peptide 1
100%
Hormone Release
100%
Diabetes
100%
Incretin
100%
Insulin Release
75%
Dipeptidyl Peptidase IV
50%
Gastric Inhibitory Polypeptide
50%
Beta Cell
50%
Insulin Like Activity
50%
Gene Expression
25%
Clinical Study
25%
Hemoglobin A1c
25%
Subcutaneous Injection
25%
Gastrointestinal Hormone
25%
Insulin Resistance
25%
Diabetes Mellitus
25%
Patient with Type 2 Diabetes
25%
Cell Growth
25%
Fatty Acid
25%
Secretion (Process)
25%
Body Weight
25%
Biochemistry, Genetics and Molecular Biology
Incretin
100%
Glucagon-Like Peptide-1
100%
Hormone Release
100%
Insulin Release
75%
Insulin Like Activity
50%
Gastric Inhibitory Polypeptide
50%
Dipeptidyl Peptidase
50%
Clinical Study
25%
Enzyme
25%
Metabolic Pathway
25%
Gene Expression
25%
Fatty Acid Level
25%
Body Weight
25%
Secretion (Process)
25%
Insulin Resistance
25%
Cell Growth
25%
Pharmacology, Toxicology and Pharmaceutical Science
Incretin
100%
Glucagon-Like Peptide-1
100%
Gastric Inhibitory Polypeptide
50%
Dipeptidyl Peptidase IV
50%
Clinical Study
25%
Subcutaneous Injection
25%
Hemoglobin A1c
25%
Fatty Acid
25%
Non Insulin Dependent Diabetes Mellitus
25%
Gastrointestinal Hormone
25%
Insulin Resistance
25%
Diabetes Mellitus
25%
Keyphrases
Treatment Modulation
100%
Agonism
100%
Cell Performance
25%
HbA1c Levels
25%